ArTS Archivio della ricerca di Trieste

MAGLI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.091
AS - Asia 870
EU - Europa 402
Continente sconosciuto - Info sul continente non disponibili 204
SA - Sud America 87
AF - Africa 14
OC - Oceania 3
Totale 2.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.034
SG - Singapore 336
IT - Italia 274
BD - Bangladesh 127
KR - Corea 126
VN - Vietnam 122
CN - Cina 60
BR - Brasile 57
CA - Canada 32
FR - Francia 27
IN - India 26
GB - Regno Unito 22
HK - Hong Kong 22
PL - Polonia 22
AR - Argentina 18
MX - Messico 14
SE - Svezia 12
AT - Austria 6
ES - Italia 6
FI - Finlandia 6
NL - Olanda 6
IQ - Iraq 5
DE - Germania 4
ID - Indonesia 4
JM - Giamaica 4
JP - Giappone 4
PH - Filippine 4
PK - Pakistan 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AU - Australia 3
AZ - Azerbaigian 3
CO - Colombia 3
EC - Ecuador 3
IL - Israele 3
JO - Giordania 3
MA - Marocco 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
IE - Irlanda 2
KE - Kenya 2
MY - Malesia 2
SV - El Salvador 2
TH - Thailandia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
KG - Kirghizistan 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.468
Salva come PNG Salva come JPEG
Città #
Singapore 242
Ashburn 227
San Jose 190
Seoul 126
Council Bluffs 121
Milan 57
New York 39
Ho Chi Minh City 38
Trieste 38
Beijing 29
Los Angeles 26
Santa Clara 25
Hong Kong 22
Hanoi 21
Rome 20
Chicago 19
Miano 18
Da Nang 14
Fairfield 12
Haiphong 12
Buffalo 11
Montreal 11
Zgierz 11
Orem 10
Atlanta 9
Denver 9
Lauterbourg 9
Palermo 9
Warsaw 9
Dallas 8
Houston 8
Olive Branch 8
Brooklyn 7
Seattle 7
London 6
Mexico City 6
Mumbai 6
Naples 6
São Paulo 6
Turin 6
Chennai 5
Florence 5
Lappeenranta 5
Philadelphia 5
Poplar 5
Toronto 5
Chandler 4
Charlotte 4
Columbus 4
Elk Grove Village 4
New Delhi 4
Palm Bay 4
Phoenix 4
Stockholm 4
Tokyo 4
Amman 3
Biên Hòa 3
Boydton 3
Brisbane 3
Colorado Springs 3
Dayton 3
Greenville 3
Jacksonville 3
Johannesburg 3
Louisville 3
North Kansas City 3
Princeton 3
Querétaro 3
Tampa 3
Tashkent 3
Vienna 3
Washington 3
Wilmington 3
Albano Laziale 2
Ann Arbor 2
Annapolis 2
Baghdad 2
Baku 2
Bari 2
Beaumont 2
Boardman 2
Bolzano 2
Boston 2
Bozeman 2
Brasília 2
Buenos Aires 2
Cambridge 2
Campinas 2
Can Tho 2
Castelfranco Veneto 2
Castelvetro di Modena 2
Champlin 2
Chiavari 2
Corpus Christi 2
Curitiba 2
Detroit 2
Dhaka 2
Dublin 2
Figino 2
Frankfurt am Main 2
Totale 1.632
Salva come PNG Salva come JPEG
Nome #
Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma 126
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 78
18F-Choline-PET-CT (PET) in N stage and radiation treatment planning (RTP) of prostate cancer patients (PCap) at High or unfavorable/intermediate risk (HUIR) 70
A multicenter study of the prognosis and treatment of adult brain ependymonal tumors. 62
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time? 60
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study 57
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: bowel dose-volume effect quantification in a multicentric cohort study 57
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 55
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 52
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy 49
PREDICTORS FOR RECTAL AND INTESTINAL ACUTE TOXICITIES DURING PROSTATE CANCER HIGH-DOSE 3D-CRT: RESULTS OF A PROSPECTIVE MULTICENTER STUDY 47
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 45
Assessment of PTV margins accounting for prostate intrafraction motion in SBRT with online IGRT 41
COVID-19 outbreak and cancer radiotherapy disruption in italy: Survey endorsed by the italian association of radiotherapy and clinical oncology (AIRO) 41
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 39
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or Gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial 39
Comparison of self-reported acute urinary incontinence in pts treated with adjuvant or salvage IMRT 39
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 37
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 36
Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT) 36
Adaptive radiotherapy nel trattamento radioterapico stereotassico ipofrazionato del tumore della prostata: Dose Tracking vs Re-Optimization 36
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 35
An image-guided SBRT phase II study with a dose of 42 Gy in 7 fractions for the localized prostate cancer 33
3T-MRI in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for CT-registration 31
Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions 31
CONTROVERSY PERSISTS OVER THE ACTUAL DOSE–VOLUME RELATIONSHIP AND INDEED WHETHER THE PENILE BULB IS JUST A SURROGATE FOR OTHER NEARBY CRITICAL STRUCTURES, ESPECIALLY GIVEN ITS LIMITED ROLE IN DEVELOPMENT AND MAINTENANCE OF ERECTIONS 30
Hyperfractionated radiotherapy for T2N0 glottic carcinoma: a retrospective analysis at 10 years follow-up in a series of 60 consecutive patients 30
Assicurazione di qualità nella radioterapia ad intensità modulata 29
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 29
Correlation Between Dose-Volume Constraints and Late Rectum Bleeding in Patients Treated for Prostate Cancer at Dose Between 70 and 76 Gy 28
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO). 28
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 28
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation 27
Assessment of PTV Margins Accounting for Prostate Intrafraction Motion in SBRT with Online IGRT 26
Breast leiomyosarcoma with myxoid aspects 25
Androgen Deprivation and Late Rectal Bleeding After Radiotherapy for Prostate Carcinoma 25
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer 25
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 24
Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial. 22
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study 21
Toxicity profile with hypofractionated RT for localized prostate cancer: compared 3D-CRT vs VMAT 21
Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study 20
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study 20
IMRT with simultaneous integrated boost and concurrent chemiotherapy for locoregionally advanced oropharynx squamous cell carcinoma: preliminary results 19
Management of de Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the Role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 19
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort 19
Dose-effect relationship for early late incontinence after IMRT in post-prostatectomy patients 19
PATIENT-SPECIFIC QA OF IMRT PLANS BY EMPLOYING AN EPID-BASED DOSE PREDICTION ALGORITHM 18
Erectile dysfunction after prostate three-dimensional conformal radiation therapy: correlation with the dose to the bulb of the penis 18
Tecnologie integrate nel trattamento oncologico dei tumori Head & Neck Innovazioni della radioterapia di interesse ORL 18
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study 18
Ruolo della TC/PET con 18F-colina nella stadiazione linfonodale e planning radioterapico nei pazienti con carcinoma della prostate a rischio alto ed intermedio sfavorevole 17
Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence 17
Prospective longitudinal evaluation of quality of life after prostate cancer IMR 17
MRI-guided contouring in SBRT of the prostate for localized disease 17
Whole-pelvic nodal irradiation with hypofractionated simultaneous integrated boost for high-risk prostate cancer: outcome and late toxicity. 17
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT 17
Safety and Efficacy of POstoPerative Ablative RadioTherapy (POPART) for Post-Prostatectomy Biochemical Recurrence 16
QUALITY INDICATORS OF INTENSITY MODULATED-IMAGE GUIDED RADIOTHERAPY (IM-IGRT) CONCOMITANT TO CHEMOTHERAPY (CT): A BENCH-MARKING ANALYSIS FOR CLINICAL AND TECHNICAL GOVERNANCE 16
Laryngeal long-term morbility after supreglottic laryngectomy and postoperative radiation therapy 16
Toxicity at 1 Year After Stereotactic Body Radiation Therapy in 3 Fractions for Localized Prostate Cancer 16
Predictors of Rectal Acute Toxicity in High-Dose 3D-CRT for Prostate Cancer. Results From a Prospective Multi-Centric Study Performed by the AIRO National Working Group on Prostate Irradiation 16
SBRT for Prostate Cancer in 3 fractions: Acute Toxicity Rates from a Prospective Multicenter Study 16
Pelvic IMRT with hypofractionated SIB to prostate for high-risk prostate cancer: a phase II study 16
Why we should take care of the competing risk bias in survival analysis: A phase II trial on the toxicity profile of radiotherapy for prostate cancer 16
Radioterapia Oncologica 15
Phase II trial of pelvic nodal irradiation with hypofractionated IMRTSIB for high-risk prostate cancer 15
Quality of life after whole pelvis RT for prostate cancer: results from a prospective study 15
Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: A multicenter study 15
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 15
DEVELOPMENT OF A SET OF NOMOGRAMS TO PREDICT ACUTE LOWER GASTROINTESTINAL TOXICITY FOR PROSTATE CANCER 3D-CRT 15
Unscheduled presentations of urological cancer outpatients in an oncology clinic: a single institution retrospective study 15
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I 15
The influence of calculation parameters on the patient-QA of p-SBRT plans with VMAT 15
Retrospective assessment of treatment planning quality in prostate SBRT 14
In prostate cancer patients (PC), PET-CT 18F-choline (FC) can incidentally discover un related diseases: our experience in 573 cases 14
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors 14
Image-guided hypofractionated radiotherapy for localized prostate cancer with 42Gy in 7 fractions: radiobiogy and preliminary clinical results of a phase II study 14
SALVAGE ELECTIVE PELVIC NODAL IRRADIATION (ENRT) COMBINED WITH FOCAL NODAL STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN THE NODAL METACHRONOUS OLIGOMETASTATIC CASTRATION-NAIVE PROSTATE CANCER: A TWOINSTITUTION EXPERIENCE 13
Linee guida carcinoma della prostata. AIOM edizione 2019 13
Dose-effect relationship for 1-year incontinence after post-prostatectomy intensitymodulated radiotherapy (MRT) 13
Il ruolo della radioterapia nel linfoma di Hodgkin: luci e ombre agli arbori del XXI secolo 13
The role of SBRT in oligorecurrent and oligoprogressive prostate cancer: a multi-institutional study 13
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water! 12
Le metastasi cerebrali: aspetti diagnostici e terapeutici 12
Radioterapia stereotassica body (42Gy in 7 frazioni settimanali) nei tumori localizzati della prostata: valutazioni radiobiologiche e primi risultati 12
STEREOTACTIC BODY RADIOTHERAPY FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER. TOXICITY RESULTS OF PHASE II STUDY 12
PRACTICE PATTERNS FOR PROSTATE CANCER IN NINE CENTRAL AND NORTHERN ITALY RADIATION ONCOLOGY CENTERS: A SURVEY INCLUDING 1759 PATIENTS TREATED DURING TWO DECADES (1980–1998) 12
La radioterapia nel trattamento degli adenomi ipofisari: risultati e prospettive 12
Il ruolo della radioterapia nel trattamento integrato del carcinoma del retto e giunzione retto-sigma 12
IG-SBRT for localized prostate cancer: clinical results and late toxicity of a phase-II study 12
IGRT con 3D-CRT ipofrazionata nel carcinoma prostatico a rischio intermedio mediante marcatori fiduciali intraprostatici: risultati di studio di fase II 11
FDG-PET/CT for target volume delineation in the intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and concurrent chemotherapy (CHT) for locoregionally advanced oropharynx squamous cell carcinoma: preliminary resuls 11
Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study 11
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 11
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 11
Stereobody radiotherapy (42Gy/7fx) for localized prostate cancer: radiobiology and first results 11
Stereotactic Radiotherapy and Androgen Deprivation Therapy for Localized Prostate Cancer: A Retrospective Mono-institutional Experience 10
Phase-II study of sbrt for localized prostate cancer: outcome and late toxicity 9
Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana Linfomi 9
Totale 2.514
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 1 0 2 0 0 1 0 1 2 0 4
2022/202316 2 2 2 0 2 3 0 1 2 0 2 0
2023/20248 0 0 1 0 1 1 2 2 0 0 0 1
2024/202514 0 0 0 1 2 2 1 1 1 2 1 3
2025/20262.268 4 0 1 266 173 226 90 75 377 541 336 179
2026/2027328 240 88 0 0 0 0 0 0 0 0 0 0
Totale 2.671